Skip to main content
Premium Trial:

Request an Annual Quote

InDevR, Applied Microarrays Partner to Deliver Custom Array Offering

NEW YORK (GenomeWeb) – InDevR and Applied Microarrays said today that they will work together to offer custom microarrays, instruments, and reagents for multiplexed assays.

The new partnership will combine Tempe, Ariz.-based AMI's background in contract custom array manufacturing with InDevR's assay development expertise and two microarray imaging platforms. Boulder, Colo.-based InDevR offers Vidia, a fluorescence-based system for scanning multiplex array and 96-well plate formats as well as a colorimetric AmpliPhox scanner for lower-throughput applications.

AMI CEO Alastair Malcolm told BioArray News that the combination of the two firm's offerings should provide their clients with "lower cost and faster turnaround time than [platforms] available from the high-density microarray providers."

Going forward, Malcolm said that AMI and InDevR will co-market their products as part of the non-exclusive agreement. He also said that AMI should benefit from its relationship with InDevR by reaching more clients and taking part in more projects.

Financial terms of the partnership were not disclosed.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.